Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A high-grade malignant vascular neoplasm that arises from the bone. It is characterized by the presence of neoplastic cells with endothelial differentiation.
Biomarker and diagnostic research for bone angiosarcoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
47 publications have been identified in PubMed for bone angiosarcoma. Research spans Case Report / Case Series (53%), Epidemiology / Natural History (13%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 25 | 53% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:47 AM UTC
Disease patterns and progression |
6 |
13% |
Research summaries | 5 | 11% |
Laboratory research | 4 | 9% |
Testing and diagnosis research | 3 | 6% |
New treatment approaches | 3 | 6% |
Clinical study results | 1 | 2% |
Hao Z (2026). [PMID: 41631010](https://pubmed.ncbi.nlm.nih.gov/41631010/). *Journal of bone oncology*. [Epidemiology / Natural History]
Kmail H (2026). [PMID: 42244020](https://pubmed.ncbi.nlm.nih.gov/42244020/). *J Med Case Rep*. [Case Report / Case Series]
Jadhav V (2026). [PMID: 40902156](https://pubmed.ncbi.nlm.nih.gov/40902156/). *Clinical nuclear medicine*. [Case Report / Case Series]
Kloker LD (2026). [PMID: 42251292](https://pubmed.ncbi.nlm.nih.gov/42251292/). *BMC Cancer*. [Epidemiology / Natural History]
He X (2026). [PMID: 41947594](https://pubmed.ncbi.nlm.nih.gov/41947594/). *Int J Immunopathol Pharmacol*. [Review / Meta-Analysis]
Öztürk R (2026). [PMID: 41758394](https://pubmed.ncbi.nlm.nih.gov/41758394/). *Archives of orthopaedic and trauma surgery*. [Basic Science / Preclinical]
Kamo Y (2026). [PMID: 40914676](https://pubmed.ncbi.nlm.nih.gov/40914676/). *Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association*. [Basic Science / Preclinical]
Chan S (2026). [PMID: 42245242](https://pubmed.ncbi.nlm.nih.gov/42245242/). *Hawaii J Health Soc Welf*. [Review / Meta-Analysis]
Rodríguez J (2026). [PMID: 41736492](https://pubmed.ncbi.nlm.nih.gov/41736492/). *Vet Comp Oncol*. [Epidemiology / Natural History]
Aertsens A (2026). [PMID: 41220190](https://pubmed.ncbi.nlm.nih.gov/41220190/). *Veterinary surgery : VS*. [Case Report / Case Series]
AI-curated news mentioning bone angiosarcoma
Updated Aug 27, 2026
A recent study highlights the challenges of diagnosing angiosarcoma in patients with lymphoedema, particularly when it presents as a chronic non-healing ulcer. This research underscores the need for heightened awareness among clinicians to improve early detection.
Recent research highlights improved oncologic outcomes for patients with radiation-associated angiosarcoma of the breast using trimodality therapy. This study underscores the potential benefits of combining surgery, radiation, and chemotherapy in treating this rare cancer.
Recent research identifies a CD163⁺/CSF1R⁺ macrophage and neutrophil-enriched phenotype in angiosarcoma, which is associated with distinct biological signatures and poor prognosis. This discovery could inform future therapeutic strategies for this aggressive cancer.